
NYXH Earnings Date: Nov 5, 2026 (Estimated) — Nyxoah S.A.
NASDAQ · Healthcare · Medical Instruments & Supplies
Updated
When is NYXH's next earnings date?
Nyxoah S.A. (NYXH) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.35 on revenue of $11.0M.
How did NYXH do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Nyxoah S.A. posted EPS of -$0.67 versus the -$0.47 estimate, a miss of 42.5%. Revenue was $8.9M against a $8.6M estimate. The stock's 1-day post-earnings move was -7.1%.
How much does NYXH stock move after earnings?
NYXH beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.1% (up or down) in the day after earnings.
About Nyxoah S.A.
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | -0.47 | -0.67 | -42.55% | $8.9M | ❌ Miss | -7.09% | +12.06% | +24.82% |
| 2026-05-12 | Q1 2026 | -0.54 | -0.43 | +20.37% | $7.5M | ✅ Beat | +0.33% | -8.47% | -51.47% |
| 2026-03-19 | Q4 2025 | -0.65 | -0.68 | -4.62% | $6.6M | ❌ Miss | -0.32% | +0.00% | +4.53% |
| 2025-11-13 | Q3 2025 | -0.61 | -0.74 | -21.31% | $2.3M | ❌ Miss | -5.84% | -14.31% | -7.91% |
| 2025-08-18 | Q2 2025 | -0.63 | -0.62 | +1.59% | $1.5M | ✅ Beat | -4.57% | -1.75% | -29.07% |
| 2025-03-13 | Q4 2024 | -0.47 | -0.49 | -4.26% | $1.3M | ❌ Miss | +3.29% | +13.57% | -38.23% |
| 2024-08-06 | Q2 2024 | -0.43 | -0.46 | -6.98% | $830,066 | ❌ Miss | +4.50% | +1.84% | -5.01% |
| 2024-05-14 | Q1 2024 | -0.42 | -0.45 | -7.14% | $1.3M | ❌ Miss | +7.20% | +4.38% | -16.18% |
Showing last 8 quarters.